Immunotherapy Weekly articles from January 2001

Immunotherapy Weekly archives from January 2001

Systemic Adverse Effects from Dust Mite Extracts Uncommon in Children.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- - by Michael Greer, staff medical writer - Despite concerns from some researchers, the use of house dust mite extracts to combat dust mite allergies in children is safe and effective, researchers in...

IgG Defeats IgE in an Antibody Battle.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Immunoglobulin G (IgG) can block IgE-induced allergic reactions. In an investigation of the characteristics of IgE binding epitopes on allergenic molecules, E. Ganglberger, of the University of...

Serum Immunoglobulin E and Eosinophil Cationic Protein May be Immunotherapy Targets.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Serum immunoglobulin E, a biomarker of atopy, and eosinophil cationic protein (ECP), a biomarker of inflammation, may be good targets for allergen-specific immunotherapy and anti-inflammation treatment...

Infliximab Safe for Children.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Infliximab, a chimeric monoclonal antibody, effective in adults with Crohn's disease, is safe and effective for children with this disease, as well. Infliximab combats intestinal inflammation due...

Topical Cyclosporine Fights Lymphocyte Activation.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Topical cyclosporine is effective against lymphocyte activation in the conjunctiva of patients with both Sjogren and non-Sjogren dry eye syndrome. Using specimens from the eyes of 12 Sjogren...

Drug Studies Show Promise for Reducing Joint Damage.(rheumatoid arthritis )
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Two studies in the November 30, 2000, issue of The New England Journal of Medicine reflect a rheumatoid arthritis (RA) research effort moving at a breathtaking pace, according to experts in the field....

Infliximab Induces Anti-Double-Stranded DNA.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Infliximab, a chimeric anti-tumor necrosis factor alpha antibody (anti-TNF alpha), can induce anti-double-stranded DNA (anti-dsDNA) production in rheumatoid arthritis (RA) patients. R.N. Maini, of...

Lingual Spray Designed to Treat Hay Fever Symptoms Rapidly.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Flemington Pharmaceutical Corporation announced December 7, 2000, that an Investigational New Drug (IND) was filed with the Division of Pulmonary Drug Products of the U.S. Food and Drug Administration...

Software Products Offer Greater Efficiency and Safety in Clinical Practice.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- BAI Clinical Software, a developer of specialty-based electronic medical record software, announced December 18, 2000, the acquisition of Cobblestone Data Systems, developer of Photomedic, an...

FDA Advisory Committee Declines to Recommend Approval of Maxamine for Metastatic Disease.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Maxim Pharmaceuticals announced December 13, 2000, that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) has declined to recommend approval of the company's...

Clinical Trial of Interleukin-1 Blocking Compound Begun.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Regeneron Pharmaceuticals, Inc. announced that it has initiated a Phase I clinical trial to assess the safety and tolerability of the company's interleukin-1 (IL-1) Cytokine Trap in patients with...

Anergy Observed Following Fluticasone Propionate Treatment in Healthy Volunteers.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Fluticasone propionate is an inhaled corticosteroid that is indicated for treating patients with asthma, allergic rhinitis, and other respiratory illnesses. New research published in the journal Chest...

Polymorphism in RANTES Gene Associated with Increased Risk.(asthma )
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Researchers in England have shown that polymorphism within the promoter region of the RANTES gene (-403*A) encodes risk for the development of asthma and atopy. Genetic and environmental factors...

Genetic Immunization Using Recombinant Alphavirus Vector of HPV Proteins Could be Therapeutic, Prophylactic.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- A recombinant Semliki Forest virus vector expressing human papillomavirus gene products appears to provide effective genetic immunization against cervical cancer in mice - even at relatively low doses....

Advisory Committee Recommends Monoclonal Antibody Therapy.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- The Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted December 14, 2000, 14 to one to recommend accelerated approval of Millennium & ILEX Partners L.P.'s...

Enzyme Inhibitor May Have Broad Application.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Vertex Pharmaceuticals Inc. (VRTX), Cambridge, Massachusetts, announced the initiation of the first human clinical trial with VX-148, a small molecule inhibitor of IMPDH (inosine monophosphate...

Memory Cells in Tonsils May Cause Long-Term Infection.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Chronic infection with the Epstein-Barr virus may be mediated, ironically, by white blood cells in the tonsils responsible for the long-term "memory" of the immune system, researchers suggest. ...

Gene Therapy Can Induce Systemic Immune Response, But Treatment Still Not Very Effective.(glioblastoma multiforme )
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Intracerebral, retrovirus-mediated, somatic gene therapy of primary glioblastoma multiforme does induce a systemic immune response in human patients, a recent study has shown, but the treatment exerted...

Endothelin-1 and Endothelin-A Receptor: Targets for Cancer Therapy?
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Endothelin-1 (ET-1) induces the growth of human papillomavirus (HPV) cells, which express endothelin-A receptors (ETAR). Thus, these receptors may be appropriate targets for anticancer therapy,...

Mechanism of Linomide Revealed.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Linomide (roquinimex), an immunomodulator, moderates the development of inflammatory diseases, and now researchers know why. "Taken together, our novel findings demonstrate that Linomide is a...

Combined Intranasal and Intramuscular Immunization Boosts Anti-Flu Response.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- A new study suggests using a combined strategy of intranasal and intramuscular immunization with either live or inactivated influenza virus enhances the immune response to flu infection. Baylor...

Study in Rat Lung Isografts Indicates Gene Therapy with Human Interleukin 10 is Effective.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Gene transfer of human interleukin 10 via adenovirus into lung isografts reduces reperfusion injury in a rat model, a study has shown. Researchers reported the results of the therapy included...

Clinical Trial for Anti-Angiogenic, Immune-Stimulating Drug Seeks Participants.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Participants are being sought in Los Angeles, California, to take part in a clinical trial with an experimental cancer drug that can be self-administered as nose drops and has a favorable safety...

Information Key Ingredient for Healthy World; NewsRx.net Offers eHealth Revenue Sharing Booster Shot.
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Health information from the Internet is the key ingredient for advancing world health, according to health publishing executive, C.W. Henderson, CEO of NewsRx. Henderson said that delivering the...

Therapeutic Antibody Licensed for Late-Stage Disease.(non-Hodgkin's lymphoma )
January 10, 2001... 2001 JAN 10 - (NewsRx.com & NewsRx.net) -- Amgen (AMGN), Thousand Oaks, California, and Immunomedics, Inc. (IMMU), Morris Plains, New Jersey, announced that the companies have signed an agreement to license to Amgen a novel cancer therapeutic...

Recombinant Human Interleukin-10 Has Therapeutic Potential.(inflammatory bowel disease )
January 17, 2001... 2001 JAN 17 - (NewsRx.com & NewsRx.net) -- Recombinant human interleukin-10 (rHuIL-10), though its effects are different in vitro compared to in vivo, has potential immunostimulating properties, and may be useful against inflammatory bowel...

Diet Affects Pathogenesis.(atherosclerosis)
January 17, 2001... 2001 JAN 17 - (NewsRx.com & NewsRx.net) -- Dietary protein type affects the development of atherosclerosis. Why plant proteins have a beneficial effect against atherosclerosis is uncertain. M. Gidlund, of the University of Sao Paulo in...

Smoking Leaves Detrimental Antibodies.(chronic obstructive pulmonary disease )
January 17, 2001... 2001 JAN 17 - (NewsRx.com & NewsRx.net) -- Antibodies, left over from their smoking days, leave ex-smokers at risk for chronic obstructive pulmonary disease (COPD). In the American Journal of Pathology, S.M. Koethe, of the Medical College...

Protectin (CD59) Regulates Susceptibility to Homologous Complement.(melanoma )
January 17, 2001... 2001 JAN 17 - (NewsRx.com & NewsRx.net) -- Overexpression of protectin (CD59), a glycosylphosphatidylinositol-anchored cell membrane glycoprotein that acts as a terminal regulator of complement (C) cascade, down-modulates the susceptibility of...

IFN-beta Has Broad Effects.(interferon)
January 17, 2001... 2001 JAN 17 - (NewsRx.com & NewsRx.net) -- Interferon-beta, approved for treatment for relapsing/remitting multiple sclerosis (RRMS), has broad immunomodulatory effects. Noting that researchers' understanding of the immunological mechanism...

Therapies Should Target p38 MAP kappa.(brain disorders)
January 17, 2001... 2001 JAN 17 - (NewsRx.com & NewsRx.net) -- p38 mitogen-activated protein kinase (p38 MAP kappa) controls neurogenic inflammation, so therapies targeted to it could prove to be effective against human brain disorders. How? B.L. Fiebich, of...

Anti-CD4 mAb Prolongs Survival.(monoclonal antibody)
January 17, 2001... 2001 JAN 17 - (NewsRx.com & NewsRx.net) -- Non-depleting anti-CD4 antibodies prolong both xenograft and allograft survival, although their effect on allografts is greater. A major contributor to transplant failure has been the...

Treatment with Anti-alphaD Monoclonal Antibodies May Be Effective.(spinal cord injury)
January 17, 2001... 2001 JAN 17 - (NewsRx.com & NewsRx.net) -- An antibody to the integrin alpha D inhibits infiltration of proinflammatory-activated monocytes/macrophages to the site of spinal cord injury. The inflammation secondary to spinal cord injury...

Company to Accelerate Development of Antibody-Based Therapeutics.(Immunomedics, cancer therapeutic antibodies)
January 17, 2001... 2001 JAN 17 - (NewsRx.com & NewsRx.net) -- Immunomedics (IMMU), Morris Plains, New Jersey, announced that the company is refocusing internal and certain external activities exclusively on its pipeline of cancer therapeutic antibodies. The...

Genetically Engineered Fibroblast Implants May Lead to New Treatment.(Parkinson's disease)
January 17, 2001... 2001 JAN 17 - (NewsRx.com & NewsRx.net) -- Neurologists with the U.S. Veterans Affairs Healthcare System have shown that Parkinson's-type brain lesions can be prevented by the implantation of fibroblasts genetically designed to secrete a...

Antiviral Therapy Relieves Certain Connective Tissue Diseases.
January 17, 2001... 2001 JAN 17 - (NewsRx.com & NewsRx.net) -- Antiviral therapy against infection with parvovirus B19 may be the answer to connective tissue disease (CTD) that is resistant to immunosuppressive therapy. CTDs, including vasculitis, systemic...

Phase IIa Clinical Trial of Monoclonal Antibody Initiated.(rheumatoid arthritis)
January 17, 2001... 2001 JAN 17 - (NewsRx.com & NewsRx.net) -- Abgenix, Inc. (ABGX), Fremont, California, announced the start of a Phase IIa multi-center clinical trial of ABX-IL8 in patients with rheumatoid arthritis. The company is also conducting a Phase...

Company Provides Update on Development of Monoclonal Antibody Therapy.(hepatitis C )
January 17, 2001... 2001 JAN 17 - (NewsRx.com & NewsRx.net) -- XTL Biopharmaceuticals Ltd. (XTL) (XTL) presented preclinical data on the company's human monoclonal antibody products (including XTL-002) being developed to treat the hepatitis C virus (HCV). The...

Tests Reveal Allergy or Non-Specific Causes.(conjunctivitis)
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- Tear immunoglobulin E (IgE) and human lymphocyte antigen-degeneration reaction (HLA-DR) expressed by conjunctival epithelium are useful tools for discriminating between an allergy-related inflammatory...

T Cells Involved in Pathogenesis.(anaphylaxis )
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- Patients who experience acute idiopathic anaphylaxis (IA) have more activated T cells than do patients in remission. No external allergen can be identified in patients with idiopathic anaphylaxis;...

Do Glucocorticoids Increase Intraocular Pressure?
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- Budesonide, a glucocorticoid used in treating asthma, does not increase intraocular pressure (IOP). Addressing the ongoing questions surrounding an association between glucocorticoids and elevated...

Lycopene Protects Against Exercise-Induced Symptoms.(asthma)
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- Lycopene, a highly active antioxidant, protects against exercise-induced asthma. The use of antioxidants for the treatment of asthma is controversial. Given this, I. Neuman and associates in Israel...

Anti-Centromere Antibodies May Act as Disease Markers.(for Raynaud's phenomenon)
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- Anti-centromere antibodies may be markers of Raynaud's phenomenon in pediatric rheumatologic diseases. E. Hossny, of Ain Shams University in Egypt, and associates investigated the presence of...

Phase II Study Can Begin in Mexico.(Multikine to treat head and neck cancer)
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- Cel-Sci Corp. (CVM) announced that the Mexican Health Authorities and the Medical Review Board at the National Cancer Institute in Mexico City have granted permission to start a Phase II clinical trial...

Collaboration Established to Accelerate Antibody Research.
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- Medarex, Inc. (MEDX), Princeton, New Jersey, Eli Lilly and Company (LLY), Indianapolis, Indiana, and Biosite Diagnostics Inc. (BSTE), San Diego, California, announced a collaborative agreement under...

Phase II Study of Humanized Antibody Initiated.(thrombocytopenic purpura )
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- IDEC Pharmaceuticals announced January 4, 2001, that it has initiated a Phase II clinical trial with its investigational agent, IDEC-131, a humanized anti-CD154 (anti-CD40L) monoclonal antibody. ...

Phase IIb ABX-IL8 Study to Proceed.(monoclonal antibody to treat psoriasis)
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- Abgenix, Inc. (ABGX), Fremont, California, announced the decision to proceed with a Phase IIb clinical trial of ABX-IL8 in patients with moderate-to-severe psoriasis. The decision to move forward...

Ibritumomab Tiuxetan Under Evaluation for Lymphatic Cancers.
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- IDEC Pharmaceuticals Corporation announced January 2, 2001, that the Biologics License Application (BLA) for Zevalin(TM) (ibritumomab tiuxetan) has been accepted for filing by the U.S. Food and Drug...

Phase III Completion of Clinical Trial Announced.(interferon alpha for Sjogren's syndrome)
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- Amarillo Biosciences, Inc. (AMAR.OB) (ABI), Amarillo, Texas, announced the completion of the company's second Phase III clinical trial in primary Sjogren's syndrome. Sjogren's syndrome is an...

Immunotherapy Added to First Cycle of Antiviral Cocktails.
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- Hemispherx Biopharma, Inc., announced January 3, 2001, a newly reviewed U.S. Food and Drug Administration (FDA) clinical protocol designed to test the blunting of the emergence of drug-resistant HIV...

Chinese Herbal Medicine May Be Useful in Treatment.(of asthma)
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- - by Michael Greer, staff medical writer -- An herbal medicine traditionally used by the Chinese to treat asthma may still be effective to prevent the symptoms of an wide array of disorders...

Fluticasone Effective for Function, Symptoms, Quality of Life.(asthma )
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- Fluticasone propionate provides for better pulmonary function, symptom improvement, and quality of life than does zafirlukast, a leukotriene-modifying drug, in asthma patients. K.T. Kim, of the...

Less Dry Powder Fluticasone for More Relief.(asthma )
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- Once-a-day inhalation of dry powder fluticasone propionate (FP) relieves asthma symptoms in children receiving frequent doses of inhaled corticosteroids. FP is, itself, a corticosteroid. Available...

Phase IIb TP10 Study Begins in Infants Undergoing High Risk Cardiac Surgery.(hypoplastic left heart syndrome)
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- Avant Immunotherapeutics, Inc. (AVAN) announced the start of a placebo-controlled, Phase IIb trial of its lead complement inhibitor, TP10, in approximately 30 infants undergoing high risk cardiac...

Treatment in Hepatitis C Patients Associated with Brain Hypometabolism.
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- We now know more about the causes of psychological disturbances related to long-term use of interferon (IFN)-alpha therapy, thanks to research conducted on patients with hepatitis C virus (HCV) by...

Actimmune Phase II Trial Initiated to Treat Atypical Disease.(myocobacterial infection treatment)
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- InterMune (ITMN), Burlingame, California, announced that it has commenced enrollment in its Phase II clinical trial evaluating the safety and efficacy of inhaled Actimmune (Interferon gamma-1b) for the...

Favorable OvaRex Phase II Trial Results Reported.
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. (AXO, ALRXF), Waltham, Massachusetts, reported the final results of one of its OvaRex Phase II trials conducted by Thomas Ehlen, MD, FRCSC, at the Vancouver Cancer Center in British...

FDA Approves Remicade with Methotrexate as First Drug to Inhibit Progression of Joint Damage.(rheumatoid arthritis)
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approved a drug to inhibit the progression of joint damage in patients with rheumatoid arthritis, which affects 2.1 million Americans, mostly women. ...

Home-Treated Patients Improve Faster than Those Hospital-Bound.(stem cell transplants )
January 24, 2001... 2001 JAN 24 - (NewsRx.com & NewsRx.net) -- Contrary to conventional medical wisdom, researchers in Sweden argue that patients who undergo allogeneic stem cell transplants recover more safely at home rather than in a hospital isolation unit. ...

Grass Pollen Immunotherapy Improves Patients' Quality of Life.
January 31, 2001... 2001 JAN 31 - (NewsRx.com & NewsRx.net) -- Undergoing grass pollen immunotherapy, also called "allergy shots," significantly reduces hay fever symptoms and medication requirements for allergy and asthma patients, according to a study in the...

Maternal Allergen Exposure Passed to Fetus.
January 31, 2001... 2001 JAN 31 - (NewsRx.com & NewsRx.net) -- Pregnant women exposed to at least one common allergen pass that exposure on to their baby through umbilical cord blood and amniotic fluid, according to pediatricians in England. "Mononuclear...

Personality Trait May Influence Immune System Response.
January 31, 2001... 2001 JAN 31 - (NewsRx.com & NewsRx.net) -- Individuals may vary in how well they can protect themselves from illness, depending on personality traits as well as on physiological differences, suggest the results of a preliminary study. Anna...

Results of Phase I Study of CETP Vaccine for Low HDL Announced.
January 31, 2001... 2001 JAN 31 - (NewsRx.com & NewsRx.net) -- Avant Immunotherapeutics (AVAN), Needham, Massachusetts, announced the results of a double-blind placebo controlled, Phase I trial of its CETP vaccine (CETi-1) in 48 healthy adult volunteers. The...

Monoclonal Antibody Inhibits HIV Entry into Cells.
January 31, 2001... 2001 JAN 31 - (NewsRx.com & NewsRx.net) -- Progenics Pharmaceuticals, Inc. (PGNX), Tarrytown, New York, announced the publication of a scientific article describing PRO 140, an inhibitor of HIV entry, which demonstrates broad and potent...

Autoantigen-Pulsed Dendritic Cells Induces Tolerance in Experimental Model.
January 31, 2001... 2001 JAN 31 - (NewsRx.com & NewsRx.net) -- An autoantigen-pulsed dendritic cell (DC) vaccine induced tolerance against experimental allergic encephalomyelitis (EAE) in a rat model, researchers in Sweden report. "DC can modulate the nature...

Antibacterial Agent in Some Medications Linked to Airway Constriction.
January 31, 2001... 2001 JAN 31 - (NewsRx.com & NewsRx.net) -- A study from the University of Florida (UF), Gainesville, provides fresh evidence that an antibacterial agent added to some asthma medications can cause airway constriction, potentially blunting the...

Interferon Receptors on Liver Tissues are Up-Regulated by Inflammatory Cytokines.
January 31, 2001... 2001 JAN 31 - (NewsRx.com & NewsRx.net) -- Certain interferon receptors are found on cancerous liver tissues as well as healthy liver tissues. Kurume University School of Medicine researchers now say that these receptors are up-regulated by...

Canine Study Reveals Positive Effects of Carprofen.
January 31, 2001... 2001 JAN 31 - (NewsRx.com & NewsRx.net) -- Carprofen, a nonsteroidal anti-inflammatory drug, has a protective effect on structure and metabolism of cartilage and subchondral bone in experimental osteoarthritis (OA) in dogs. These positive...

Pivotal U.S. Phase III Program Begins with Zadaxin Plus Pegylated Alfa Interferon.(hepatitis C )
January 31, 2001... 2001 JAN 31 - (NewsRx.com & NewsRx.net) -- SciClone Pharmaceuticals (SCLN), San Mateo, California, announced that it has initiated its pivotal U.S. Phase III hepatitis C clinical program for Zadaxin in combination with Pegasys, pegylated...

Clinical Trial of Transfected Xenogeneic Cells Begins in Patients with Metastases.
January 31, 2001... 2001 JAN 31 - (NewsRx.com & NewsRx.net) -- Researchers in France have initiated a Phase I clinical trial of xenogeneic cells transfected with interleukin-2 (IL-2) in patients with metastatic tumors. "Various studies have emphasized an...

Hepatitis C Patients with Kidney Disease See Limited Relief with Interferon.
January 31, 2001... 2001 JAN 31 - (NewsRx.com & NewsRx.net) -- New research indicates that interferon therapy can help some hepatitis C virus infected patients with cryoglobulinemic glomerulonephritis, but additional studies are needed. Hepatitis C virus...

Flt3 Ligand Augments Immune Response.(HIV vaccines )
January 31, 2001... 2001 JAN 31 - (NewsRx.com & NewsRx.net) -- The ability of HIV vaccines to marshal the body's defenses against the infection can be enhanced by concomitant treatment with Flt3 ligand, study results suggest. "Liposomes and Flt3 ligand...